UNS 0.00% 0.5¢ unilife corporation

Wearable Injectors, page-2

  1. 725 Posts.
    lightbulb Created with Sketch. 98
    firstly, if they didn't have patents then pharmas wouldn't deal with them because it is a highly competitive and fierce industry and if you go onto the AUS patent website you'll see abbvie has filed a patent for wearable injector device and if you read the document it is a UNS 1ml WI device, so expect Humira in it. Secondly there planning to outsource manufacturing to flextronics which they announced a couple of years ago and if you go onto flextronics website then you will see pictures of unilifes wearable injectors. With the PFS, they are a low margin, high CAPEX product compared to the wearables which all they have to do is the RnD and then outsource manufacturing until they can afford to invest in their own manufacturing lines. I still believe in UNS because of the people they have and the partners they have, nothing happens overnight in the pharma space, it takes years!
 
watchlist Created with Sketch. Add UNS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.